FontsA A
ContrastA A
Newsletter sign-up
I agree with the regular receipt of the newsletter of BBMRI-ERIC. The subscription to the newsletter can be canceled at any time (see privacy notice) )

EU Grants

To date, BBMRI-ERIC has been awarded more than €7 million in additional funds thanks to its participation in the EU’s 7th Framework Programme and Horizon 2020.

As its main goal, BBMRI-ERIC aims to improve the accessibility and interoperability of existing collections of biological samples from different (sub)populations of Europe, including both population-based and clinically-oriented sample collections.

Including 20 Members, BBMRI-ERIC is a globally unmatched, Europe-wide platform for translational medical research with the aim to develop personalised medicine and disease prevention for the benefit of European citizens.

How to partner up with us


We welcome requests from individual researchers as well as research teams seeking project collaborations with BBMRI-ERIC and/or its National Nodes. Please send an email to with the following information:

  • Name of the PI
  • Call ID and call text
  • Aim of the proposal (short description)
  • Desired collaboration/contribution of BBMRI-ERIC
  • Adherence to non-exclusivity

Discover all the EU projects we participate in


The ADOPT BBMRI-ERIC (implementAtion anD OPeration of the gateway for healTh into BBMRI-ERIC) proposal aims at boosting and accelerating the implementation of BBMRI-ERIC and its services.


B3Africa (Bridging Biobanking and Biomedical Research across Europe and Africa) will dramatically improve and facilitate the development of better predictive, preventive and personalised healthcare worldwide.


Thousands of circulating proteins have been shown to be hallmarks of emerging disease, response to treatment, or a patients’ prognosis. The identification of these small molecule biomarkers holds a great promise for significant improvement of personalized medicine based on simple blood tests.

To increase the number of clinically validated biomarkers, rather than further increasing the number of biomarker discovery studies, CliniMARK will improve the quality and reproducibility of studies and establish a coherent biomarker development pipeline from discovery to market introduction.


The overall goal of EDIReX is to establish a cutting-edge European infrastructure offering Trans-national Access (TA) of PDX resources to academic and industrial cancer researchers, including the distribution of cryopreserved samples to third parties, the structured biobanking of user-developed models, and the performance of efficacy studies.


EOSC-hub builds on existing technology already at TRL 8 and addresses the need for interoperability by promoting the adoption of open standards and protocols.


EPTRI is aimed at harnessing the research and services for the development of medicines for children as well as identifying gaps in paediatric medicines research preventing efficient use of research technologies across pertinent medicine research fields, from discovery and preclinical phase, all the way to ameliorate the therapeutic use of medicines in clinical practice. Sharing understanding of patients’ needs and concerted efforts in critical areas of research will end in further enhancing the health of children and will also have a positive impact on European competitiveness in the pharmaceutical sector.


Despite examples of excellent practice, rare diseases (RD) research is still mainly fragmented by data and diseaese types. Individual efforts have little interoperability and almost no systematic connection between detailed clinical and genetic information, biomaterial availability or research/trial datasets.

By developing robust mechanisms and standards for linking and exploiting these data, RD-Connect will develop a critical mass for harmonisation and provide a strong impetus for a global ‘trial-ready’ infrastructure ready to support the IRDiRC goals for diagnostics and therapies for RD in close collaboration with the succesful A/B projects.

Completed Projects


The goal of AARC2 is to design an AAI framework to develop an interoperable AAI to enable researchers to access the whole research and infrastructure service portfolio with one login.


The aim of this project is to exploit research capacities built in Central Europe with support from the European Structural and Investment Fund and develop a cutting-edge research platform capable of addressing major scientific and societal challenges in contemporary Europe in the areas of environment and health.


CORBEL will establish a collaborative framework of shared services between the ESFRI Biological and Medical Research Infrastructures that transform the European research community from discovery of basic biological mechanisms to applied medical translation – through the provision of a unified interface, aligned services and coordinated user access to a range of advanced technology platforms.


The BBMRI-ERIC EGI (European Clinical Research Infrastructures Network) Competence Centre focuses on helping BBMRI-ERIC to bridge the implementation of big data storage in combination with data analysis and data federation using EGI-federated cloud infrastructure.


The EOSCpilot project will support the first phase in the development of the European Open Science Cloud (EOSC) as described in the EC Communication on European Cloud Initiatives.


During the next 10 years, a significant number of the 742,000,000 European citizens will have their genome determined routinely. This will be complemented with much cheaper measurement of the metabolome of biofluids which will link the genotype with data on the exposome of patients, which for the first time enables the development of a truly personalised and hand-tailored medicine based on hard scientific measurement.


The overarching goal of RItrain is to identify the competency requirements for the leadership of European research infrastructures (RI) and design a training programme to fulfil these requirements. Our highest priority is those professionals who are already working in research infrastructures, including directors, coordinators, senior project managers, legal representatives, heads of Finance and HR, and heads of communication.


Molecular in vitro diagnostics and biomedical research have allowed great progress in personalised medicine but further progress is limited by insufficient guidelines for pre-analytical workflow steps (sample collection, preservation, etc.) as well as by insufficient quality assurance of diagnostic practice. This allows using compromised patients’ samples with post collection changes in cellular and extra-cellular biomolecules’ profiles thus often making diagnostic test results unreliable or even impossible.

Thus, SPIDA4P aims to generate and implement a comprehensive portfolio of 22 pan-European pre-analytical CEN/TS and ISO/IS, addressing the important pre-analytical workflows applied to personalized medicine.

You may also be interested in

National Nodes

National Nodes & contact points for local biobanks

orange-markerFind our National Nodes
and contact points for local biobanks.




... read more

Partner up with us

We welcome requests from individual researchers as well as research teams seeking project collaborations with BBMRI-ERIC and/or its National Nodes.

... read more
Recent News

BBMRI-ERIC Assembly of Members Approves Work Programme for 2019

... read more

Register for our next BBMRI-ERIC Webinar: Data Quality for Biobanks

... read more

This website was co-funded within ADOPT BBMRI-ERIC, a project that has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 676550.
We use cookies to analyse the traffic on our websites. All personal data is anonymized and not shared with third parties! Click here for more information.